| Bioactivity | SDZ NVI 085 is a compound with CNS stimulatory effects, primarily through the α1-adrenoceptor subtype, with anti-cataplexy and anti-stroke activities. SDZ NVI 085 also has a significant alertness effect and can be used to study other types of excessive sleepiness[1]. |
| CAS | 104195-17-7 |
| Formula | C15H21NO2S |
| Molar Mass | 279.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. A Renaud, et al. Effects of SDZ NVI-085, a putative subtype-selective α1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep. European journal of pharmacology 205.1 (1991): 11-16. |
SDZ NVI 085
CAS: 104195-17-7 F: C15H21NO2S W: 279.40
SDZ NVI 085 is a compound with CNS stimulatory effects, primarily through the α1-adrenoceptor subtype, with anti-catapl
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.